AbCellera Biologics Inc. (ABCL)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $5.1M
- Sep 1 · Unusual
- Form 4 sales
- 8
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJun 9 2021
Sold 1M shares at $25.50 ($25.5M)
Falconer Ester, Chief Technology Officer
Sold 100% of holdings ($25.5M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 saleUnusualJun 9 same day
Sold 1.2M shares at $25.50 ($30.6M)
Booth Andrew, Chief Financial Officer
Sold 100% of holdings ($30.6M position)0 shares leftFirst sale on recordFiling
- 3 Form 4 saleUnusualJun 9 same day
Sold 1M shares at $25.50 ($25.5M)
Stimart Tryn, Chief Legal Officer
Sold 100% of holdings ($25.5M position)250 shares leftFirst sale on recordFiling
- 4 Form 4 saleUnusualJun 9 same day
Sold 1M shares at $25.50 ($25.5M)
Lecault Veronique, Chief Operating Officer
Sold 78.5% of holdings ($32.5M position)273,630 shares leftFirst sale on recordFiling
- 5 Form 4 saleUnusualJun 9 same day
Sold 6M shares at $24.13 ($145M)
Hansen Carl L. G., Chief Executive Officer
Sold 96.3% of holdings ($150M position)233,500 shares leftFirst sale on recordFiling
- 6 Form 4 salePlan not statedJun 9 same day
Sold 5.6M shares at $24.03 ($135M)
Thermopylae Holdings Ltd., 10% owner
Sold 9.1% of holdings ($1.5B position)55.6M shares leftFirst sale on recordFiling
- 7 Form 4 salePlan not statedJun 22 +13 days
Sold 100,000 shares at $25.50 ($2.5M)
Hayden Michael R, Director
Sold 9.1% of holdings ($28.1M position)1M shares leftFirst sale on recordFiling
- 8 Form 4 saleUnusualSep 1 +71 days
Sold 300,000 shares at $16.94 ($5.1M)
Hamer John, Director
Sold 70% of holdings ($7.3M position)128,862 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (8)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Hamer John | Director | Form 4 sale | 300,000 | $5.1M | 70.0% | Unusual | SEC |
| Jun 22, 2021 | Hayden Michael R | Director | Form 4 sale | 100,000 | $2.5M | 9.1% | Plan not stated | SEC |
| Jun 9, 2021 | Thermopylae Holdings Ltd. | 10% owner | Form 4 sale | 5.6M | $135M | 9.1% | Plan not stated | SEC |
| Jun 9, 2021 | Hansen Carl L. G. | Chief Executive Officer | Form 4 sale | 6M | $145M | 96.3% | Unusual | SEC |
| Jun 9, 2021 | Lecault Veronique | Chief Operating Officer | Form 4 sale | 1M | $25.5M | 78.5% | Unusual | SEC |
| Jun 9, 2021 | Stimart Tryn | Chief Legal Officer | Form 4 sale | 1M | $25.5M | 100.0% | Unusual | SEC |
| Jun 9, 2021 | Booth Andrew | Chief Financial Officer | Form 4 sale | 1.2M | $30.6M | 100.0% | Unusual | SEC |
| Jun 9, 2021 | Falconer Ester | Chief Technology Officer | Form 4 sale | 1M | $25.5M | 100.0% | Unusual | SEC |